Literature DB >> 20938674

Proliferative and migratory aptitude in pterygium.

Haiqing Bai1, Yufei Teng, Lee Wong, Vishal Jhanji, Chi-Pui Pang, Gary Hin-Fai Yam.   

Abstract

Pterygium is a chronic fibrovascular overgrowth on the corneal surface and is often associated with inflammation, astigmatism and obstructed vision. The common treatment is surgical removal but post-operative recurrences with more aggressive behavior are common. However, there is a controversy in the pathogenesis of primary pterygium between limbal stem cell failure versus proliferation. In this study, we explore the proliferative and migratory aptitude in pterygium by characterizing the growth and migration pattern of pterygial cells in the head (on the cornea), the neck (over the focal limbus), and the body (on the conjunctiva) epithelia of 12 full-length primary pterygia. Immunofluorescence and quantification analyses showed a spatial expression pattern of markers for stem cells, cell growth, and matrix metalloproteinases. Beside the basal epithelia in all three regions, p63α(strong) cells were located in suprabasal layers in head, weak in the body and absent in neck. Pertinent cell proliferation in head than body epithelia was revealed by its higher colony-forming efficiency. ATP-binding cassette transporter glycoprotein family member-2 and cytokeratin-15 were found mainly in the body basal epithelia, similar to that in normal conjunctiva. Much fewer proliferating stem-like cells in the neck region supported the limbal failure as a cause of pterygium formation. Pax6, matrix metalloproteinase-2 and -9 were more expressed in the head than in the other two regions. Our results indicate the importance of pterygium head in tissue growth and invasion and its likely involvement in post-operation recurrence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20938674     DOI: 10.1007/s00418-010-0751-5

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  23 in total

Review 1.  The treatment of pterygium.

Authors:  Lawrence W Hirst
Journal:  Surv Ophthalmol       Date:  2003 Mar-Apr       Impact factor: 6.048

2.  Expression of p63 in pterygium and normal conjunctiva.

Authors:  Pornpilas Sakoonwatanyoo; Donald T H Tan; Duncan R Smith
Journal:  Cornea       Date:  2004-01       Impact factor: 2.651

3.  Expression of p63 and p16 in primary and recurrent pterygia.

Authors:  Fernando S Ramalho; Claudia Maestri; Leandra N Z Ramalho; Alfredo Ribeiro-Silva; Erasmo Romão
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-08       Impact factor: 3.117

Review 4.  Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives (Review).

Authors:  Efstathios T Detorakis; Demetrios A Spandidos
Journal:  Int J Mol Med       Date:  2009-04       Impact factor: 4.101

Review 5.  Matrix metalloproteinase proteomics: substrates, targets, and therapy.

Authors:  Charlotte J Morrison; Georgina S Butler; David Rodríguez; Christopher M Overall
Journal:  Curr Opin Cell Biol       Date:  2009-07-16       Impact factor: 8.382

6.  Developmental and cellular factors underlying corneal epithelial dysgenesis in the Pax6+/- mouse model of aniridia.

Authors:  Thaya Ramaesh; Kanna Ramaesh; J Martin Collinson; Simon A Chanas; Baljean Dhillon; John D West
Journal:  Exp Eye Res       Date:  2005-08       Impact factor: 3.467

7.  Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells.

Authors:  N Dushku; M K John; G S Schultz; T W Reid
Journal:  Arch Ophthalmol       Date:  2001-05

8.  Increased expression of gelatinase (MMP-2 and MMP-9) in pterygia and pterygium fibroblasts with disease progression and activation of protein kinase C.

Authors:  Shun-Fa Yang; Ching-Yang Lin; Pei-Yu Yang; Shih-Chun Chao; Yi-Zhen Ye; Dan-Ning Hu
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-06       Impact factor: 4.799

9.  Study of the expression of CD30 in pterygia compared to healthy conjunctivas.

Authors:  Yonathan Garfias; Víctor Manuel Bautista-De Lucio; Cynthia García; Angel Nava; Leonardo Villalvazo; María Carmen Jiménez-Martínez
Journal:  Mol Vis       Date:  2009-10-17       Impact factor: 2.367

10.  The role of Pax-6 in eye and nasal development.

Authors:  J C Grindley; D R Davidson; R E Hill
Journal:  Development       Date:  1995-05       Impact factor: 6.868

View more
  12 in total

Review 1.  Histochemistry and cell biology: the annual review 2010.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2011-01-29       Impact factor: 4.304

Review 2.  The role of heredity in pterygium development.

Authors:  Peter Anguria; James Kitinya; Sam Ntuli; Trevor Carmichael
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

3.  What biomarkers explain about pterygium OCT pattern.

Authors:  Sara Lluch; Gemma Julio; Pere Pujol; Dolores Merindano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01       Impact factor: 3.117

4.  Effects of intraoperative steroid injection on the outcome of pterygium surgery.

Authors:  A Kheirkhah; R Nazari; H Safi; H Ghassemi; M J Behrouz; V K Raju
Journal:  Eye (Lond)       Date:  2013-07-26       Impact factor: 3.775

5.  Expression of vascular endothelial growth factor C in human pterygium.

Authors:  Junichi Fukuhara; Satoru Kase; Tsutomu Ohashi; Ryo Ando; Zhenyu Dong; Kousuke Noda; Takeshi Ohguchi; Atsuhiro Kanda; Susumu Ishida
Journal:  Histochem Cell Biol       Date:  2012-08-23       Impact factor: 4.304

Review 6.  Pterygium: an update on pathophysiology, clinical features, and management.

Authors:  Toktam Shahraki; Amir Arabi; Sepehr Feizi
Journal:  Ther Adv Ophthalmol       Date:  2021-05-31

7.  Expression of cell proliferation and apoptosis biomarkers in pterygia and normal conjunctiva.

Authors:  Kun Liang; Zhengxuan Jiang; Bi-qing Ding; Ping Cheng; Da-ke Huang; Li-ming Tao
Journal:  Mol Vis       Date:  2011-06-23       Impact factor: 2.367

8.  Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13.

Authors:  Yeoun-Hee Kim; Jae-Chang Jung; Sang Il Gum; Su-Bin Park; Jin Yeul Ma; Yong Il Kim; Kyoo Won Lee; Young Jeung Park
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

9.  Autophagy mediates cell cycle response by regulating nucleocytoplasmic transport of PAX6 in limbal stem cells under ultraviolet-A stress.

Authors:  Maria Laggner; Andreas Pollreisz; Gerald Schmidinger; Ursula Schmidt-Erfurth; Ying-Ting Chen
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

10.  Cosmetic Pterygium Surgery: Techniques and Long-Term Outcomes.

Authors:  Arun C Gulani; Aaishwariya A Gulani
Journal:  Clin Ophthalmol       Date:  2020-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.